Detected ·

Golgenia Srl

——

Golgenia Srl, an oncology biotech developing a novel approach to reverse tumor resistance to chemotherapy, has completed its seed round with Creadd Ventures as Lead Investor, joined by Indaco Venture Partners SGR and Ruby Direct Opportunity Fund SCSP.

Website
—
LinkedIn
—
Amount
—
Stage
—
Event
Funding round
Detected
2026-08-11 16:05:11 UTC
Signal ID
1fe48cf9-abb8-4814-8132-7a5ddf2e2d69

As the API returns it

{
  "id": "1fe48cf9-abb8-4814-8132-7a5ddf2e2d69",
  "created_at": "2026-08-11T16:05:11.671615Z",
  "company_name": "Golgenia Srl",
  "company_website_url": null,
  "company_linkedin_url": null,
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Golgenia Srl, an oncology biotech developing a novel approach to reverse tumor resistance to chemotherapy, has completed its seed round with Creadd Ventures as Lead Investor, joined by Indaco Venture Partners SGR and Ruby Direct Opportunity Fund SCSP.*"
}

Latest rounds

FLEXECHARGE——LinkedIn
Nimesis Technology€550KOtherLinkedIn
Remanence$30MSeedLinkedIn
Noeri$110M—LinkedIn
Nimesis Technology——Site / LinkedIn
Nomadic Drones$6MSeedSite / LinkedIn
ODAIA—Series CLinkedIn
Remanence$30MSeedLinkedIn
Model ML$250MSeries BLinkedIn
Commit Biologics$60MSeedLinkedIn
Treat Health€3MPre-SeedLinkedIn
Tiberius Aerospace$85MSeries ASite / LinkedIn
Numa$45MSeries CLinkedIn
ODAIA—Series CSite / LinkedIn
Pulpex£24.6MSeries DSite / LinkedIn
Q-CTRL$290MSeries CLinkedIn
Arva AI$20MSeries ALinkedIn
Arva AI$20MSeries ASite / LinkedIn
Fairly$22.4MSeries ASite / LinkedIn
Previsia€3.8MSeedSite / LinkedIn
August AI$12M—Site / LinkedIn
MountAIn€7.3M—Site / LinkedIn
Treat Health€3M—Site / LinkedIn
Gotham FC$100MOtherSite / LinkedIn
Isomorphic Labs$5B—Site / LinkedIn
End Close$3.5MSeed—
Model ML$250MSeries BSite / LinkedIn
Remanence$30M——
Remanence$30M——
Hadl.ai——LinkedIn
Remanence€27.2MSeed—
Bricks Performance SystemDKK 1.5M—Site / LinkedIn
Noeri$110M——
Remedy Robotics$62MOtherLinkedIn
COUNT$6.5MSeedSite / LinkedIn
Nimble Science—AngelSite / LinkedIn
Corma$125MSeries A—
Bedrock Energy$24M—LinkedIn
Corma$125MSeries ALinkedIn
ComeHome—OtherSite / LinkedIn
Queens Court Capital——Site / LinkedIn
FLEXECHARGE——Site / LinkedIn
Numa$45MSeries CLinkedIn
The Vaccine Group (TVG)£500KOtherSite / LinkedIn
AgentWeb—Other—
Corma$125MSeries ALinkedIn
Geminus—Other—
Drogue—Pre-SeedSite / LinkedIn
Traitomic€20M—LinkedIn
Centese——Site / LinkedIn